John Bigalke Biography and Net Worth

Director of Premier

John Bigalke has been a member of the Premier board of directors since 2019. He has served as the Chief Executive Officer of Second Half Healthcare Advisors, a healthcare strategy firm in Orlando, Florida, since founding the firm in 2016. He was previously with Deloitte USA LLP from 1998 to 2016, where he served as Vice Chairman and National Industry Leader for the Health Care and Life Science Practice from 2002 until 2012 and vice chairman and senior partner, Global Health Care Practice from 2012 to 2016.

Bigalke currently serves on the boards of directors of Progenity Inc., a NASDAQ-listed biotechnology company (chair of the Audit Committee and Special Committee and member of Nominating and Governance Committee), and AdventHealth (non-voting member of Audit Committee, Finance and Strategy Committee and Risk and Corporate Responsibility Committee). He also serves on the Advisory Board of Concord Healthcare Management Services LLC and Vaxcare Inc. (chair). He previously served on the boards of Deloitte USA LLP (chair of Audit and Finance committee and member of Executive Committee, Risk Committee and Strategy Committee) and the Healthcare Financial Management Association (Strategy Committee and Executive Committee).

Bigalke obtained a bachelor’s degree from Clemson University. He completed the Leadership Development Program at Columbia University Graduate School of Business and the Executive Leadership Program at the Wharton School of the University of Pennsylvania. Bigalke is a licensed Certified Public Accountant.

What is John T. Bigalke's net worth?: The estimated net worth of John T. Bigalke is at least $575,929.20 as of March 5th, 2025. Bigalke owns 29,810 shares of Premier stock worth more than $575,929 as of April 21st. This net worth approximation does not reflect any other assets that Bigalke may own. Learn More about John T. Bigalke's net worth.
How do I contact John T. Bigalke?: The corporate mailing address for Bigalke and other Premier executives is 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. Premier can also be reached via phone at (704) 357-0022 and via email at angie_mccabe@premierinc.com. Learn More on John T. Bigalke's contact information.
Has John T. Bigalke been buying or selling shares of Premier?: John T. Bigalke has not been actively trading shares of Premier during the past quarter. Most recently, John T. Bigalke sold 1,137 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $17.54, for a transaction totalling $19,942.98. Following the completion of the sale, the director now directly owns 29,810 shares of the company's stock, valued at $522,867.40. Learn More on John T. Bigalke's trading history.
Who are Premier's active insiders?: Premier's insider roster includes Michael Alkire (CEO), Leigh Anderson (Insider), John Bigalke (Director), Helen Boudreau (Director), Andy Brailo (Insider), Stephen D'Arcy (Director), Jody Davids (Director), David Hargraves (SVP), David Klatsky (General Counsel), William Mayer (Director), and Craig Mckasson (CFO). Learn More on Premier's active insiders.
Are insiders buying or selling shares of Premier?: In the last twelve months, insiders at the sold shares 30 times. They sold a total of 363,849 shares worth more than $7,373,385.41. The most recent insider tranaction occured on April, 2nd when General Counsel David L Klatsky sold 10,000 shares worth more than $195,300.00. Insiders at Premier own 1.0% of the company. Learn More about insider trades at Premier.
Information on this page was last updated on 4/2/2025.

John T. Bigalke Insider Trading History at Premier

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/5/2025	Sell	1,137	$17.54	$19,942.98	29,810
12/5/2024	Sell	1,136	$22.19	$25,207.84	23,846

John T. Bigalke Buying and Selling Activity at Premier

Premier Company Overview

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.

Today's Range

Now: $19.32

$19.13

$19.42

50 Day Range

MA: $18.69

$17.46

$19.68

2 Week Range

Now: $19.32

$17.23

$23.56

Volume

1,254,048 shs

Average Volume

1,264,418 shs

Market Capitalization

$1.76 billion

P/E Ratio

N/A

Dividend Yield

4.32%

Beta

0.51